Skip to content

TEVA TEVA PHARMACEUTICAL INDS LTD

Follow

Common / Ordinary Stock (common), issuer CIK 818686

1 manager (1 13F filer) reported a position in TEVA shares at 2026-06-30, 11,849 shares in all. 1 filer opened a position and 0 filers sold out during the quarter.

Managers
1
13F filers
1
New
1
Added
0
Reduced
0
Sold out
0
Shares held by filers
11,849

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Bergwerk Dovofficer (Interim Chief Legal Officer)2026-11-15+8,370 MForm 4
Sabag Markofficer (See "Remarks")2026-11-12-44,710 S$44.141Form 4
Sabag Markofficer (See "Remarks")2026-11-12+44,710 M$34.9Form 4
Daniell Richardofficer (EVP, Europe Commercial)2026-11-11-20,003 S$42.8013Form 4
Daniell Richardofficer (EVP, Europe Commercial)2026-11-11+20,003 M$34.7Form 4
Francis Richard Dofficer (President and CEO)2026-11-10-250,000 S$42.2367Form 4
Daniell Richardofficer (EVP, Europe Commercial)2026-11-09-25,000 S$42.9116Form 4
Daniell Richardofficer (EVP, Europe Commercial)2026-11-09+25,000 M$34.7Form 4
Weiss Amirofficer (Chief Accounting Officer)2026-11-09-9,534 S$43.0289Form 4
Weiss Amirofficer (Chief Accounting Officer)2026-11-09-7,093 S$43.0349Form 4
Weiss Amirofficer (Chief Accounting Officer)2026-11-09-662 S$43.15Form 4
Weiss Amirofficer (Chief Accounting Officer)2026-11-09+7,755 M$34.7Form 4
Sabag Markofficer (See "Remarks")2026-11-05-46,000 S$41.9289Form 4
Sabag Markofficer (See "Remarks")2026-11-05+46,000 M$34.9Form 4
Bergwerk Dovofficer (Interim Cheif Legal Officer)2026-11-04-8,755 S$41.72Form 4

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
DGS Capital Management, LLCin group DGS Capital Management, LLC11,849$401K0.05%new13F-HRTimelineGroup

Events

  • Bergwerk Dov acquired 8,370 TEVA shares on 2026-11-15, Form 4 filed 2026-11-17. 0001193125-26-465483

    Accepted , ingested
  • Phoenix Financial Ltd. reported 56,550,149 TEVA shares, 4.85% of the class, as of 2026-11-04, in a 13G/A filed 2026-11-16. 0001178913-26-005243

    Accepted , ingested
  • Daniell Richard reported transactions in TEVA shares with no net change in a Form 4 filed 2026-11-12. 0001193125-26-458451

    Accepted , ingested
  • Francis Richard D sold 250,000 TEVA shares on 2026-11-10, Form 4 filed 2026-11-12. 0001193125-26-458424

    Accepted , ingested
  • Sabag Mark reported transactions in TEVA shares with no net change in a Form 4 filed 2026-11-12. 0001193125-26-458410

    Accepted , ingested
  • Weiss Amir disposed of 9,534 TEVA shares on 2026-11-09, Form 4 filed 2026-11-12. 0001193125-26-458383

    Accepted , ingested
  • Sabag Mark reported transactions in TEVA shares with no net change in a Form 4 filed 2026-11-06. 0001193125-26-451814

    Accepted , ingested
  • Bergwerk Dov reported transactions in TEVA shares with no net change in a Form 4 filed 2026-11-06. 0001193125-26-451804

    Accepted , ingested
  • Harel Insurance Investments & Financial Services Ltd. reported 70,418,201 TEVA shares, 6% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-02. 0001178913-26-004925

    Accepted , ingested